CRT 2026
Late-Breaking Clinical Trial
Karen M. Kim, MD
Associate Professor of Cardiovascular and Thoracic Surgery
University of Texas Health Austin/Dell Medical School
Austin, Texas, United States
Disclosure(s): No financial relationships to disclose
Kusum Lata, MD, FSCAI
Interventional Cardiology
Sutter Health, CA
Tracy, California, United States
Disclosure(s): No financial relationships to disclose
Gary M. Ansel, MD, FACC
Founder
Healthcare Inroads
Columbus , Ohio, United States
Disclosure information not submitted.
Robert Dieter, MD
Disclosure information not submitted.
Steven L. Goldberg, MD, FSCAI, FACC
Interventional Cardiologist
Three Crosses Regional Medical Center, Las Cruces, New Mexico
Monterey, California, United States
Disclosure(s): Abbott Labs: Consulting Fees (e.g., advisory boards) (Ongoing), Proctor (Ongoing); Cardiac Dimensions.: Consulting Fees (e.g., advisory boards) (Ongoing), Stock Options [in privately held companies] (Ongoing)
Ziyad Ghazzal, MD
Director, Heart, Vascular & Kidney Outpatient Center
American University of Beirut Medical Center
American University of Beirut
Riad El Solh, Beyrouth, Lebanon
Disclosure(s): No financial relationships to disclose
Issam Moussa, MD
Medical Director, Carle Heart & Vascular Institte
Carle Health / University of Illinois Urbana Champaign
Dallas, Texas, United States
Disclosure(s): No financial relationships to disclose
Aravinda Nanjundappa, MD, FSCAI
Director of Peripheral Vascular Interventions, Cardiovascular Division
Cleveland Clinic , Main Campus
Pepper pike, Ohio, United States
Disclosure(s): No financial relationships to disclose
Horst Sievert, MD, FSCAI, FACC, FESC
Director
CardioVascular Center Frankfurt CVC
Frankfurt, Hessen, Germany
Disclosure(s): Abbott, Ablative Solutions, Adona Medical, Akura Medical, Ancora Heart, Append Medical, Axon, Bavaria Medizin Technologie GmbH, BioRefine, Boston Scientific, Canon, Cardiac Dimensions, Cardiac Success, Cardimed, Cardionovum, Contego, Coramaze: Study honoraria, travel expenses, consulting fees to institution (Ongoing); Croivalve, CSL Behring LLC, CVRx, Dinova, Eclipse, Endobar, Endologix, Endomatic, Esperion Therapeutics, Inc., Hangzhou Nuomao Medtech, Holistick Medical, Intershunt, Intervene, Laminar, Lifetech, Magenta, Maquet Getinge Group, Metavention, Mitralix: Study honoraria, travel expenses, consulting fees to institution (Ongoing); Mokita, Myotec, Neurotronic, Novelrad, NXT Biomedical, Occlutech, Recor, Renal Guard, Shifamed, Terumo, Tonic Medical, Trilio, Trisol, TruLeaf, Vascular Dynamics, Vectorious Medtech, Venus, Venock, Vivasure Medical, Vvital Biomed, Whiteswell, Xenter: Study honoraria, travel expenses, consulting fees to institution (Ongoing)
Luca Testa, MD, PhD, Professor of Cardiology
Head of Coronary Revascularization Unit; Head of Clinical Research Unit
IRCCS Pol. S. Donato, Milan, Italy
Roma, Lazio, Italy
Disclosure(s): No financial relationships to disclose
Olga Toleva, MD, MPH
Lead of Advanced Coronary Physiology Program
Georgia Heart Institute
Gainesville, Georgia, United States
Disclosure information not submitted.
On Topaz, MD
Professor of Medicine ,Duke University School of Medicine.
Duke University School of Medicine/Charles George VAMCCharles George Veterans Affairs MCCharles George Veterans Affairs MC
Biltmore Lake, North Carolina, United States
Disclosure(s): Angiodynamics/Auryon: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)